FTC sues main pharmacy advantage managers about insulin selling prices The company brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of everyday living-preserving insulin medications. Insurers will carry on vertically integrating to help keep far more profits https://kethek.com/